ES477517A1 - Procedimiento para la preparacion de nuevos derivados car- bostirilicos y oxindolicos. - Google Patents
Procedimiento para la preparacion de nuevos derivados car- bostirilicos y oxindolicos.Info
- Publication number
- ES477517A1 ES477517A1 ES477517A ES477517A ES477517A1 ES 477517 A1 ES477517 A1 ES 477517A1 ES 477517 A ES477517 A ES 477517A ES 477517 A ES477517 A ES 477517A ES 477517 A1 ES477517 A1 ES 477517A1
- Authority
- ES
- Spain
- Prior art keywords
- group
- carbon atoms
- oxindolic
- derivatives
- procedure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000004432 carbon atom Chemical group C* 0.000 abstract 8
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 abstract 2
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 abstract 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
- 125000006839 xylylene group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Indole Compounds (AREA)
Abstract
Procedimiento para la preparación de nuevos derivados carbostirílicos y oxindólicos de la fórmula general **fórmula** en donde WQ significa un grupo vinileno eventualmente sustituido con un grupo metilo, el grupo metileno o etileno, m significa los números 0 1 o 2, D significa un grupo alcohileno de cadena recta o ramificado con 2 hasta 6 átomos de carbono, un grupo hidroxialcohileno de cadena recta o ramificado con 3 hasta 6 átomos de carbono o un grupo xilileno, R1 significa un átomo de hidrógeno o un grupo alcohilo con 1 hasta 3 átomos de carbono, R2 significa un grupo cicloalcohilo con 3 hasta 6 átomos de carbono, un grupo arilo con 6 hasta 10 átomos de carbono, un grupo aralcohilo con 7 hasta 11 átomos de carbono, un grupo heteroarilo con 4 hasta 9 átomos de carbono, que contiene un átomo de nitrógeno y/o un átomo de oxígeno o un átomo de azufre o dos átomos de nitrógeno o un grupo heteroaralcohilo con 5 hasta 10 átomos de carbono, pudiendo estar los núcleos aromáticos, expuestos anteriormente, mono sustituidos con un grupo alcohilo
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19782806721 DE2806721A1 (de) | 1978-02-17 | 1978-02-17 | Neue carbostyril-derivate |
| DE19782853314 DE2853314A1 (de) | 1978-12-09 | 1978-12-09 | Neue carbostyril- und oxindolderivate, ihre herstellung und ihre verwendung als arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES477517A1 true ES477517A1 (es) | 1980-01-16 |
Family
ID=25773852
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES477517A Expired ES477517A1 (es) | 1978-02-17 | 1979-02-07 | Procedimiento para la preparacion de nuevos derivados car- bostirilicos y oxindolicos. |
| ES484633A Expired ES484633A1 (es) | 1978-02-17 | 1979-10-01 | Procedimiento para la preparacion de nuevos derivados car- bostirilicos y oxindolicos |
| ES484634A Expired ES484634A1 (es) | 1978-02-17 | 1979-10-01 | Procedimiento para la preparacion de nuevos derivados car- bostirilicos y oxindolicos |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES484633A Expired ES484633A1 (es) | 1978-02-17 | 1979-10-01 | Procedimiento para la preparacion de nuevos derivados car- bostirilicos y oxindolicos |
| ES484634A Expired ES484634A1 (es) | 1978-02-17 | 1979-10-01 | Procedimiento para la preparacion de nuevos derivados car- bostirilicos y oxindolicos |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0003771B1 (es) |
| JP (1) | JPS54132581A (es) |
| AT (1) | AT374183B (es) |
| AU (1) | AU523147B2 (es) |
| CA (1) | CA1116600A (es) |
| CS (1) | CS227005B2 (es) |
| DD (1) | DD141829A5 (es) |
| DE (1) | DE2963868D1 (es) |
| DK (1) | DK157017C (es) |
| ES (3) | ES477517A1 (es) |
| FI (1) | FI69064C (es) |
| GR (1) | GR66565B (es) |
| HK (1) | HK50485A (es) |
| HU (1) | HU177522B (es) |
| IE (1) | IE48179B1 (es) |
| IL (1) | IL56677A (es) |
| NO (1) | NO152839C (es) |
| NZ (1) | NZ189685A (es) |
| PH (1) | PH16698A (es) |
| PL (3) | PL119177B1 (es) |
| PT (1) | PT69244A (es) |
| RO (2) | RO76683A (es) |
| SU (2) | SU843739A3 (es) |
| YU (1) | YU41146B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1171624B (it) * | 1980-11-12 | 1987-06-10 | Thomae Gmbh Dr K | Indolinoni dotati di proprieta' farmaceutiche e procedimento per la loro produzione |
| US4442111A (en) * | 1981-07-25 | 1984-04-10 | Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung | Antithrombotic sulfimino and sulfoximino indolinones-2 |
| DE3217012A1 (de) * | 1982-05-06 | 1983-11-10 | Dr. Karl Thomae Gmbh, 7950 Biberach | Benzoxazin-2-one, deren herstellung und diese verbindungen enthaltende arzneimittel |
| AU653060B2 (en) * | 1991-08-23 | 1994-09-15 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivative and platelet agglutination inhibitor |
| JP2004529110A (ja) | 2001-03-06 | 2004-09-24 | アストラゼネカ アクチボラグ | 脈管損傷活性を有するインドール誘導体 |
| MY129350A (en) | 2001-04-25 | 2007-03-30 | Bristol Myers Squibb Co | Aripiprazole oral solution |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5082218A (es) * | 1973-11-10 | 1975-07-03 | ||
| US3904761A (en) * | 1974-01-25 | 1975-09-09 | Hoechst Co American | Method of preventing thrombosis |
| US4070470A (en) * | 1974-06-24 | 1978-01-24 | Otsuka Pharmaceutical Co., Ltd. | Platelet aggregation inhibiting carbostyrils, their compositions and method of use |
| JPS5321176A (en) * | 1976-08-09 | 1978-02-27 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivatives |
| IE46852B1 (en) * | 1977-06-10 | 1983-10-05 | Otsuka Pharma Co Ltd | Novel carbostyril derivatives |
-
1979
- 1979-01-31 SU SU792716799A patent/SU843739A3/ru active
- 1979-02-07 EP EP79100348A patent/EP0003771B1/de not_active Expired
- 1979-02-07 DE DE7979100348T patent/DE2963868D1/de not_active Expired
- 1979-02-07 ES ES477517A patent/ES477517A1/es not_active Expired
- 1979-02-08 AT AT0093379A patent/AT374183B/de active
- 1979-02-12 GR GR58339A patent/GR66565B/el unknown
- 1979-02-13 DD DD79211007A patent/DD141829A5/de unknown
- 1979-02-14 RO RO7996613A patent/RO76683A/ro unknown
- 1979-02-14 RO RO79103556A patent/RO82013A/ro unknown
- 1979-02-15 IL IL56677A patent/IL56677A/xx unknown
- 1979-02-15 FI FI790507A patent/FI69064C/fi not_active IP Right Cessation
- 1979-02-15 YU YU366/79A patent/YU41146B/xx unknown
- 1979-02-16 HU HU79TO1094A patent/HU177522B/hu unknown
- 1979-02-16 IE IE313/79A patent/IE48179B1/en unknown
- 1979-02-16 JP JP1716179A patent/JPS54132581A/ja active Granted
- 1979-02-16 PL PL1979222632A patent/PL119177B1/pl unknown
- 1979-02-16 PL PL1979222631A patent/PL119423B1/pl unknown
- 1979-02-16 AU AU44329/79A patent/AU523147B2/en not_active Ceased
- 1979-02-16 PL PL1979213471A patent/PL117771B1/pl unknown
- 1979-02-16 NZ NZ189685A patent/NZ189685A/en unknown
- 1979-02-16 DK DK069679A patent/DK157017C/da not_active IP Right Cessation
- 1979-02-16 PT PT69244A patent/PT69244A/pt unknown
- 1979-02-16 NO NO790521A patent/NO152839C/no unknown
- 1979-02-19 CS CS791091A patent/CS227005B2/cs unknown
- 1979-02-19 CA CA000321738A patent/CA1116600A/en not_active Expired
- 1979-10-01 ES ES484633A patent/ES484633A1/es not_active Expired
- 1979-10-01 ES ES484634A patent/ES484634A1/es not_active Expired
- 1979-10-24 SU SU792835387A patent/SU852170A3/ru active
-
1980
- 1980-08-01 PH PH24380A patent/PH16698A/en unknown
-
1985
- 1985-07-04 HK HK504/85A patent/HK50485A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK167886A (da) | 9-(fosfonylmethoxyalkyl)adeniner, fremgangsmaade til fremstilling og brug af disse | |
| SE7605246L (sv) | Bindemedel | |
| ES450643A1 (es) | Procedimiento para la preparacion de derivados de pirrolidi-na. | |
| ES483311A1 (es) | Un procedimiento para preparar derivados de prolina | |
| ES474562A1 (es) | Procedimiento para la obtencion de derivados de 1-alcanoil- prolina | |
| ES477517A1 (es) | Procedimiento para la preparacion de nuevos derivados car- bostirilicos y oxindolicos. | |
| ES463971A1 (es) | Perfeccionamientos en o relacionados con compuestos organi- cos. | |
| ES470745A1 (es) | Un procedimiento para preparar derivados de 6,6'-oxibis-pi- rona halo-sustituida | |
| ES453861A1 (es) | Un procedimiento para la preparacion de nuevos derivados de indazol. | |
| ES471745A1 (es) | Procedimiento para la obtencion de derivados del benzopirano. | |
| ES461691A1 (es) | Un procedimiento para la preparacion de sales de compuestos. | |
| KR830003406A (ko) | 제초성을 가진 치환된 디페닐에테르의 제조방법 | |
| ES465322A1 (es) | Un procedimiento para preparar compuestos e imericos de 4"- amino. | |
| ES8102091A1 (es) | Procedimiento para preparar (n-cianoimido) carbonatos disus-tituidos | |
| ES453276A1 (es) | Procedimiento para la preparacion de nuevos derivados de i- midazol y tetrazol. | |
| ES8300091A1 (es) | Procedimiento para preparar derivados de indol o de indolina | |
| ES462746A1 (es) | Procedimiento para la preparacion de nuevas piridobenzodia- zepinas. | |
| ATE15667T1 (de) | Neue substituierte 3,5-diamino-1,2,4-oxadiazole und 3,5-diamino-1,2,4-thiadiazole, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate. | |
| JPS548627A (en) | 2-alkoxyalkoxy-5-nitrobenzenesulfonic acid and its salt | |
| KR910000691A (ko) | 간질치료제로서의 5-페닐-2-푸란 케톤의 용도 | |
| ES281404A1 (es) | Procedimiento para la preparación de difenilalquilaminas | |
| SE8302084D0 (sv) | New benzimidazole derivatives | |
| ES460297A1 (es) | Un compuesto. | |
| ES451741A2 (es) | Procedimiento para preparar derivados de naftiridina. | |
| ES356717A1 (es) | Procedimiento para la preparacion de nuevos esteres difeni-licos. |